Connect with us

Hi, what are you looking for?

World

Aspirin does not improve survival in Covid-19 patients: UK study, Europe News & Top Stories


LONDON (REUTERS) – Aspirin does not improve the chances of survival in severely ill Covid-19 patients, early results from one of Britain’s biggest trials studying the commonly used painkiller and blood thinner showed on Tuesday (June 8).

The scientists behind the trial, which is looking into a range of potential treatments for Covid-19, evaluated aspirin’s effects on nearly 15,000 hospitalised patients infected with the novel coronavirus.

Since the drug helps reduce blood clots in other diseases, it was tested in Covid-19 patients who are at a higher risk of clotting issues.

“Although aspirin was associated with a small increase in the likelihood of being discharged alive, this does not seem to be sufficient to justify its widespread use for patients hospitalised with Covid-19,” said Peter Horby, co-chief investigator of the trial.

In the study, named RECOVERY, a little less than half of the patients were selected at random and given 150mg of aspirin once a day, and the remaining were given usual care alone.

The trial, run by the University of Oxford, is also looking at the effectiveness of several other treatments, and was the first to show that the widely available steroid dexamethasone, could save lives of people severely ill with Covid-19. The aspirin study did not show any significant change to the risk of patients progressing to invasive mechanical ventilation.

For every 1,000 patients treated with the medicine, about six more patients experienced a major bleeding event and about six fewer experienced a clotting event, Oxford said.

Oxford said the results would be published on online portal medRxiv, and have been submitted for publication at a peer-reviewed medical journal.

RECOVERY also showed anti-inflammatory treatment tocilizumab significantly reduced deaths, but found no benefit for Covid-19 patients from drugs such as antibiotic azithromycin and anti-malarial drug hydroxychloroquine.





Source link

Leave your vote

Comments

0 comments

You May Also Like

Politics

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae.

Finance

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Politics

Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum.

Finance

Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora.

Log In

Forgot password?

Forgot password?

Enter your account data and we will send you a link to reset your password.

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Add to Collection

No Collections

Here you'll find all collections you've created before.